Comparative study to examine the effects of changing between thienopyridine drugs on platelet aggregation activity for patients who are consistently treated with dual antiplatelet therapy: DAPT (clopidogrel + aspirin) over 52 weeks
Phase of Trial: Phase II
Latest Information Update: 20 Mar 2019
Price : $35 *
At a glance
- Drugs Prasugrel (Primary) ; Clopidogrel
- Indications Ischaemic heart disorders
- Focus Therapeutic Use
- Acronyms CONVERT 2
- 25 Oct 2018 Status changed from recruiting to completed.
- 29 Jun 2017 Status changed from not yet recruiting to recruiting.
- 11 May 2017 New trial record